HPV Genotypes of Senegalese Women Attending Radiotherapy

Objectives: This work was carried out in order to determine the profile of different HPV genotypes in a population of women attending radiotherapy (RT). Material and Methods: This is a retrospective study. Sixty paraffin blocks were chosen by simple random method upon 1015 blocks of cervix cancer diagnosed in Senegal’s public hospitals laboratories of anatomopa-thology. The strains of HPV genotyping were done with polymerase chain reaction (PCR) multiplex using primers MY09-MY11, GP5+ and GP6+. Results: Among the sixty examined blocks, DNA extraction was unsatisfactory in three cases. All women were infected with HPV high risk (HR). The different HPV genotypes isolated were HPV 16 (49/96%), 18 (8/16%), 35 (7/14%), 45 (4/8%), and 58 (2/4%). It was a single infection in 36 cases (70, 60%), co-infection in 11 cases (21, 60%) and a multi-infection in 4 cases (7, 80%). Conclusion: The prevalence of HPV found in our series is comparable to that found in the world. To complete this study, a large population of Senegalese patients with uterine cervix cancer (CC) and HPV genotype, is needed to determine if HPV genotypes could be considered as a prognostic marker in patients with uterine CC after RT.


Introduction
Human papillomavirus (HPV) is responsible for more than 493,000 cases of cervical cancer worldwide each year and about 274,000 deaths worldwide [1].
Highly oncogenic human papillomavirus (HPV) infections are responsible for 7.7% of cancers in developing countries, mainly cervical cancer. The incidence of this cancer is emerging steadily increasing in sub-Saharan Africa, with more than 75,000 new cases and close to 50,000 deaths a year, a toll further increased by HIV infection. According to the World Health Organization, cervical cancer will kill more than 443,000 women per year worldwide by 2030, nearly 90% of them in sub-Saharan Africa [2].
Persistent high-risk HPV (HR-HPV) infection is involved in more than 90% of cervical cancer cases and has been identified as a causal factor in development of cancer [3]. Generally, HPV16 and HPV18 cause about 70% of cervical cancer cases [4].
In Senegal, cervical cancer (CC) is the first cancer in terms of frequency and mortality among women [5]. This is a public health problem hence the urgency of preventive measures, including vaccination [6]. A preliminary study in four regions of Senegal in 936 asymptomatic women showed a prevalence of 18.1% of high-risk HPV infection (HPV-HR). HPVs-HR types found in order of frequency were HPV31 (25.9%), HPV52 (19.4%), HPV45 (13.5%), HPV16 (13%) and HPV51 (10.6%) [5].
The strong correlation between the presence of HPV and the development of cervical cancer has enabled the research lead to the development of two vaccines.
However, these vaccines only cover a few HPV genotypes, others have not been the subject of vaccine development, but seem to be a problem, demonstrated by various studies in Africa [7].
The primary treatment strategy for uterine CC consists of surgery or radiotherapy (RT). Surgery is usually reserved for early-stage disease and small lesions including stage IA, IB1, and selected IIA1 diseases [8]. Based on the results of randomized clinical trials, chemoradiotherapy (CCRT) has become the main treatment for stage IB2 to IVA disease [9]. YOKO et al. study suggests that HPV negative patients with cervical cancer have a significantly poorer prognosis after radiotherapy, and HPV status may be used as a marker to optimize the treatment of patients with this type of cancer [10].
Senegal is a developing country that has difficulty in getting his medical platform with radiotherapy and molecular biology.
This work was carried out in order to determine the profile of different HPV genotypes in a population of women attending radiotherapy (RT), in order to integrate them after into understanding the response to radiotherapy.

DNA extraction
Depending on the size of the lesion, 1-3 µm FFPE sections were obtained. The utmost care was taken during the cutting protocol in order to avoid contamination [11]. Sections were deparaffinized with 1 ml of xylene at 56˚C for 5 min.

HPV Genotype Distribution among HPV-Positive cervix cancer
The analysis showed that among the 54 women, fifty one (94%) were infected with at least one type of oncogenic risk HPV of which 36 had a single HPV type infection, 11 had co-infection, and rest 4 had infection with more than two types of HPV (Table 1).
In our study we isolated few cases of multiple infections: 30% of women had two or more types of HPV. In contrast, 70% of women had one type of HPV infection. The most common type of infections found in this study was respectively HPV-16 (67%) and HPV-35 (4%). Co-infection with HPV 16 and 18 was found (8%) ( Table 2).

HPV Prevalence by Age
Analysis of the prevalence of HR-HPVs by age showed an overwhelming presence of these viruses in all age group, with greater positivity in patients over 40 years old (73%). The hpv-16 showed much frequency rates, with a maximum in the group more than 40 years old (98%). The age does not predict significantly about HPV type (Table 3).

Discussion
The present study is the first to show the distribution of human papillomavirus genotypes before RT in Senegalese patients with uterine Cervix Cancer (CC).   were the most common genotypes for uterine CC in the world [15]. However, Salehi-Vaziri et al. reported that the most common HPV genotypes in Iranian women were HPV 16 and 53 [16]. García Muentes et al. reported that the most common HPV genotypes in Ecuadorian women were HPV 16 and HPV 33 [17].
A fairly important patient rate (30%) in the study was positive for several HPV types (Table 1). A recent study in a Colombian population found 62.5% of multiple infections among HPV-infected women by conventional PCR [18]. The frequency of multiple infections found in our study as compared to this may reflect that multiple infections are a common phenomenon.
Our results collaborate with those of Muñoz and colleagues who reported frequencies of 91.9% and 8.1% for single and multiple infections, respectively [19].
Radiotherapy induces high levels of DNA damage in tumor cells with the aim to promote apoptosis. The addition of cisplatin to radiotherapy increased anti-tumor effects, and has been shown to improve therapy outcome in cervical cancer [20]. DNA DSBs, as induced by radiotherapy, can be repaired by two fundamentally distinct pathways: non-homologous end-joining (NHEJ) and homologous recombination (HR) [21].
HPV infection has been linked to altered DNA repair through various mechanisms. Importantly, expression of HPV oncogenes appears to negatively impact the ability to repair DNA, pointing at an increased sensitivity of HPV-positive cells, such as most cervical cancer cells, for genotoxic agents [22].
Others studies results indicate that patients with high initial HPV titers could be favorably treated with radiotherapy alone. Chemotherapy in HPV positive tumors could be ineffective since in vitro studies have been reported these to be chemoresistant, while HPV negative cells were found to be chemosensitive [23] [24].
In our study, the positive HPV rate is above 80%. Given this HPV positivity rate in our series, it is important to discuss the association chemotherapy in the management of this cancer in our country.  [31].
Another study showed that HPV16 positivity was significantly associated with improved prognosis in the whole series of cervical cancer and also in subgroup receiving primary RT/CCRT [32]. Given the number of HPV 16 in our series, we can expect a very good response from our patients treated with exclusive radiotherapy.
In vitro studies have revealed significant differences in biological behaviors between HPV types. For example, HPV16 is associated with a higher level of tumor apoptosis than HPV18, affording one possible explanation for more radiosensitive cervical cancer with HPV16 [33].
Given the much lower prevalence of HPV18 in cervical cancer than HPV16, independent studies with large sample size are needed to assess the impact of HPV18 on patients' prognosis.
About the multiple infections, some considered that older women with different new sexual partners might be tended to infect with multiple HPV [34] [35].
Furthermore, since HPV16, the most oncogenic HPV known, was detected in all CC cases, the presence of other HPV types in the same lesions may represent concomitant infections. It remains to be determined to which extent each virus contributes to the prognostic in radiotherapy.
One of the limitations of our study was that we could not include the response after radiotherapy. Because the machine broke down for the duration of the study. In addition, there was a phenomenon of loss of sight of patients.

Conclusion
In conclusion, the results of the present study further evidence for the notion Open Journal of Biophysics that cervical HPV infection, also with multiple types, is widespread. However, further large population studies on the usefulness HPV genotype information in Senegalese patients with uterine CC are needed to determine if HPV genotypes could be considered as a prognostic marker in patients with uterine CC after RT.